Sequenta researches and develops immuno-sequencing products for diagnosing and treating cancer, autoimmune disorders and infectious diseases.
Business Model:
Revenue: $0
Employees: 51-200
Sequenta was acquired by
Adaptive Biotechnologies.
The acquisition happend on 2015-01-07.
Details of the transaction were not public
Address: 329 Oyster Point Blvd
City: South San Francisco
State: CA
Zip: 94080
Country: US
Sequenta researches and develops immuno-sequencing products for diagnosing and treating cancer, autoimmune disorders and infectious diseases.
Contact Phone:
+18885528988
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2012 | Venture Round | 3 | $8.5M |
Index Ventures Farzad (Zod) Nazem Mohr Davidow Ventures Index Ventures Farzad (Zod) Nazem Mohr Davidow Ventures |
7/2009 | Venture Round | $2M | 7/2013 | Series C | 3 | $20M |
Index Ventures Foresite Capital Mohr Davidow Ventures Foresite Capital Index Ventures Foresite Capital Mohr Davidow Ventures Foresite Capital |
2/2012 | Equity | $8.5M |
Mohr Davidow Ventures |
10/2014 | Equity | - | 10/2014 | Venture Round | 1 | - |
Celgene Celgene Celgene Celgene |
12/2010 | Series B | 4 | $13M |
Mohr Davidow Ventures Jacob Goldfield Index Ventures Mohr Davidow Ventures Farzad (Zod) Nazem Mohr Davidow Ventures Jacob Goldfield Index Ventures Mohr Davidow Ventures |
10/2014 | Equity | - |
Celgene Corporation Celgene Corporation |
10/2014 | Venture Round | 1 | - |
Celgene Celgene Celgene Celgene |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|